SWOG clinical trial number
SWOG-9420

A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer

Closed
Phase
III
Accrual
100%
Published
Abbreviated Title
A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer
Activated
04/15/1995
Closed
05/15/1999

Research committees

Gastrointestinal Cancer

Treatment

5-Fluorouracil

Publication Information Expand/Collapse

2018

Survival by Hispanic Ethnicity among Cancer Patients Participating in SWOG Clinical Trials

M Chavez-MacGregor;J Unger;A Moseley;S Ramsey;DL Hershman Cancer Apr 15;124(8):1760-1769; Jan 25 [Epub ahead of print]

PMid: PMID29370458 | PMC number: PMC5963502

The association between ASCO Value framework and scientific and clinical impact of SWOG phase III clinical trials

V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster

2017

Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials

H Greenlee;J Unger;M Leblanc;S Ramsey;D Hershman Cancer Epidemiology Biomarkers & Prevention 2017 Jan;26(1):21-29; 2016 Dec 16. [Epub ahead of print]

PMid: PMID27986655 | PMC number: PMC5370550

Patterns of osteoporosis (OP) in survivors of colorectal cancer (CRC) enrolled on SWOG trials

A Barzi;D Hershman;C Till;H Lenz;H Hochster;W Barlow;J Unger J Clin Oncol 35, 2017 (suppl; abstr 10056); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session

2014

Association between BMI at treatment initiation and cancer survival across multiple SWOG trials

H Greenlee;J Unger;M Leblanc;D Hershman AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster

2005

Assessment of infusional 5-fluorouracil schedule and dose intensity. a Southwest Oncology Group and Eastern Cooperative Oncology Group study

CG Leichman;JK Benedetti;MM Zalupski;H Hochster;AF Shields;HJ Lenz;JL Wade;JD Bearden;JS Macdonald Clinical Colorectal Cancer 5(2):119-123

2001

Phase III trial of protracted infusion (PI) vs intermittent high-dose infusion (HDI) 5-fluorouracil (5-FU) in patients (PTS) with disseminated colorectal cancer (DCRC): a Southwest Oncology Group (SWOG) and Eastern Cooperative Oncology Group (ECOG) study.

CG Leichman;J Benedetti;H Hochster;M Zalupski;A Benson;J Macdonald Proc of the American Society of Clinical Oncology 20:125a(#497)

Other Clinical Trials

SWOG Clinical Trial Number
S9304A-ICSC

Investigation of Thioredoxin-1 Family Protein Expression in Rectal Cancer

Research Committee(s)
Gastrointestinal Cancer
Closed
SWOG Clinical Trial Number
SWOG-8037

Combined Therapies for Squamous Cell Carcinoma of the Esophagus

Research Committee(s)
Gastrointestinal Cancer
Activated
02/16/1981
Closed
01/19/1984
Closed
Phase
II
Published
SWOG Clinical Trial Number
SWOG-8591(NCI Intergroup #0035)

An Evaluation of Levamisole Alone or Levamisole plus 5-Fluorouracil as Surgical Adjuvant Treatment for Resectable Adenocarcinoma of the Colon

Research Committee(s)
Gastrointestinal Cancer
Activated
01/14/1985
Closed
10/01/1987
Closed
Phase
Published